ArticleBMC pulmonary medicine2020

NTP42, a novel antagonist of the thromboxane receptor, attenuates experimentally induced pulmonary arterial hypertension.

Eamon P Mulvaney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.